PL366705A1 - Interferon gamma polypeptide variants - Google Patents

Interferon gamma polypeptide variants

Info

Publication number
PL366705A1
PL366705A1 PL02366705A PL36670502A PL366705A1 PL 366705 A1 PL366705 A1 PL 366705A1 PL 02366705 A PL02366705 A PL 02366705A PL 36670502 A PL36670502 A PL 36670502A PL 366705 A1 PL366705 A1 PL 366705A1
Authority
PL
Poland
Prior art keywords
interferon gamma
polypeptide variants
gamma polypeptide
variants
interferon
Prior art date
Application number
PL02366705A
Other languages
English (en)
Polish (pl)
Inventor
Anne Dam Jensen
Original Assignee
Maxygen Holdings Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Holdings Ltd. filed Critical Maxygen Holdings Ltd.
Publication of PL366705A1 publication Critical patent/PL366705A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL02366705A 2001-04-06 2002-04-04 Interferon gamma polypeptide variants PL366705A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200100579 2001-04-06
DKPA200100714 2001-05-07
DKPA200200198 2002-02-11

Publications (1)

Publication Number Publication Date
PL366705A1 true PL366705A1 (en) 2005-02-07

Family

ID=27222504

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02366705A PL366705A1 (en) 2001-04-06 2002-04-04 Interferon gamma polypeptide variants

Country Status (15)

Country Link
EP (1) EP1412382A2 (xx)
JP (1) JP2005518183A (xx)
KR (1) KR20030094336A (xx)
CN (1) CN1257186C (xx)
BG (1) BG108256A (xx)
BR (1) BR0208596A (xx)
CA (1) CA2443277A1 (xx)
HK (1) HK1069834A1 (xx)
HU (1) HUP0303645A3 (xx)
IL (1) IL157896A0 (xx)
MX (1) MXPA03009082A (xx)
NO (1) NO20034432L (xx)
NZ (1) NZ528651A (xx)
PL (1) PL366705A1 (xx)
WO (1) WO2002081507A2 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2390262A1 (en) 2003-05-16 2011-11-30 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
JP4707327B2 (ja) * 2004-01-27 2011-06-22 旭化成ファーマ株式会社 ポリペプタイド類の吸着防止剤
KR20070085227A (ko) * 2004-08-09 2007-08-27 앨리오스 바이오파마 인크. 합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
JP5769142B2 (ja) * 2007-09-04 2015-08-26 独立行政法人酒類総合研究所 ピヒア属酵母において異種タンパク質を高分泌させる方法
EP2039764A1 (en) * 2007-09-19 2009-03-25 Pevion Biotech AG Truncated secretory aspartyl proteinase 2
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
RU2446821C2 (ru) * 2010-07-15 2012-04-10 Олег Ильич Эпштейн Лекарственное средство для лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способ лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями
GB201621728D0 (en) 2016-12-20 2017-02-01 Ucb Biopharma Sprl Methods
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
WO2023182947A1 (en) * 2022-03-22 2023-09-28 Chiang Mai University A modified protein of interferon gamma and its use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
BG52073B2 (en) * 1990-01-24 1996-04-30 Inst Molekuljarna Biolog Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine
DE4036856C1 (xx) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De

Also Published As

Publication number Publication date
CN1257186C (zh) 2006-05-24
NO20034432L (no) 2003-10-29
CA2443277A1 (en) 2002-10-17
JP2005518183A (ja) 2005-06-23
BG108256A (bg) 2004-12-30
HK1069834A1 (en) 2005-06-03
HUP0303645A3 (en) 2005-12-28
MXPA03009082A (es) 2004-11-22
WO2002081507A2 (en) 2002-10-17
BR0208596A (pt) 2004-03-09
IL157896A0 (en) 2004-03-28
NO20034432D0 (no) 2003-10-03
WO2002081507A3 (en) 2004-02-12
EP1412382A2 (en) 2004-04-28
HUP0303645A2 (hu) 2004-01-28
NZ528651A (en) 2006-06-30
CN1537117A (zh) 2004-10-13
KR20030094336A (ko) 2003-12-11

Similar Documents

Publication Publication Date Title
HK1069834A1 (en) Interferon gamma polypeptide variants
EP1499352A4 (en) ANTI-INTERLEUKIN-9 RECOMBINANT ANTIBODIES
AU2002367859A8 (en) Polypeptide immobilization
EP1412499A4 (en) CYTOKINE POLYPEPTIDES
GB0100196D0 (en) Peptides
GB0201679D0 (en) Polypeptide variants
PL375218A1 (en) Recombinant protein variants
EP1359932A4 (en) TIP39 POLYPEPTIDES
GB0218977D0 (en) Polypeptide
GB0109438D0 (en) Peptides
GB0112342D0 (en) Polypeptides
GB0223193D0 (en) Polypeptide
GB0103517D0 (en) Polypeptide
PL375202A1 (en) Cytokine polypeptides
GB0208925D0 (en) Polypeptide
GB0101739D0 (en) Novel polypeptide
EP1373306A4 (en) PROTEINS ASSOCIATED WITH CYTOSKELETON
EP1477559A4 (en) NEW POLYPEPTIDE
GB0111031D0 (en) Novel polypeptide
GB0107394D0 (en) Novel polypeptide
GB0100039D0 (en) Novel polypeptide
GB0104118D0 (en) Novel polypeptide
GB0101222D0 (en) Novel polypeptide
EP1362865A4 (en) CYCLIC PEPTIDE
GB0108218D0 (en) New polypeptide

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)